SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001663577-24-000234
Filing Date
2024-08-15
Accepted
2024-08-15 13:21:48
Documents
48
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q skvi10q2_063024.htm   iXBRL 10-Q 497152
2 GRAPHIC image_001.jpg GRAPHIC 8053
3 GRAPHIC image_002.jpg GRAPHIC 8465
9 CERTIFICATION ex31_1.htm EX-31.1 9099
10 CERTIFICATION ex31_2.htm EX-31.2 9019
11 CERTIFICATION ex32_1.htm EX-32.1 4151
  Complete submission text file 0001663577-24-000234.txt   2498739

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE skvi-20240630.xsd EX-101.SCH 20505
5 XBRL CALCULATION FILE skvi-20240630_cal.xml EX-101.CAL 33620
6 XBRL DEFINITION FILE skvi-20240630_def.xml EX-101.DEF 50720
7 XBRL LABEL FILE skvi-20240630_lab.xml EX-101.LAB 156498
8 XBRL PRESENTATION FILE skvi-20240630_pre.xml EX-101.PRE 128923
51 EXTRACTED XBRL INSTANCE DOCUMENT skvi10q2_063024_htm.xml XML 222919
Mailing Address 6320 S SANDHILL ROAD UNIT 9 LAS VEGAS NV 89120
Business Address 6320 S SANDHILL ROAD UNIT 9 LAS VEGAS NV 89120 702-433-7154
SKINVISIBLE, INC. (Filer) CIK: 0001085277 (see all company filings)

IRS No.: 880344219 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25911 | Film No.: 241211475
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)